Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Female reproductive factors, menopausal hormone use, and Parkinson's disease.

Liu R, Baird D, Park Y, Freedman ND, Huang X, Hollenbeck A, Blair A, Chen H.

Mov Disord. 2014 Jun;29(7):889-96. doi: 10.1002/mds.25771. Epub 2013 Dec 18.

2.

Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study.

Schonfeld SJ, Ron E, Kitahara CM, Brenner A, Park Y, Sigurdson AJ, Schatzkin A, de González AB.

Cancer Epidemiol. 2011 Dec;35(6):e85-90. doi: 10.1016/j.canep.2011.05.009. Epub 2011 Aug 17.

3.

Reproductive factors and Parkinson's disease risk in Danish women.

Greene N, Lassen CF, Rugbjerg K, Ritz B.

Eur J Neurol. 2014 Sep;21(9):1168-77, e68. doi: 10.1111/ene.12450. Epub 2014 Apr 22.

PMID:
24750445
4.

Reproductive factors and risk of Parkinson's disease in women: A meta-analysis of observational studies.

Lv M, Zhang Y, Chen GC, Li G, Rui Y, Qin L, Wan Z.

Behav Brain Res. 2017 Sep 29;335:103-110. doi: 10.1016/j.bbr.2017.07.025. Epub 2017 Jul 22. Review.

PMID:
28743601
5.

Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study.

Kabat GC, Park Y, Hollenbeck AR, Schatzkin A, Rohan TE.

Int J Cancer. 2011 Feb 15;128(4):944-50. doi: 10.1002/ijc.25413.

6.

Reproductive factors and Parkinson's disease: a multicenter case-control study.

Nicoletti A, Nicoletti G, Arabia G, Annesi G, De Mari M, Lamberti P, Grasso L, Marconi R, Epifanio A, Morgante L, Cozzolino A, Barone P, Quattrone A, Zappia M.

Mov Disord. 2011 Dec;26(14):2563-6. doi: 10.1002/mds.23951. Epub 2011 Sep 28.

PMID:
21956541
7.

Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.

Daugherty SE, Lacey JV Jr, Pfeiffer RM, Park Y, Hoover RN, Silverman DT.

Int J Cancer. 2013 Jul 15;133(2):462-72. doi: 10.1002/ijc.28022. Epub 2013 Feb 12.

8.

Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.

Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, Dahm CC, Kaaks R, Lukanova A, Boeing H, Schütze M, Trichopoulou A, Bamia C, Kyrozis A, Sacerdote C, Agnoli C, Palli D, Tumino R, Mattiello A, Bueno-de-Mesquita HB, Ros MM, Peeters PH, van Gils CH, Lund E, Bakken K, Gram IT, Barricarte A, Navarro C, Dorronsoro M, Sánchez MJ, Rodríguez L, Duell EJ, Hallmans G, Melin BS, Manjer J, Borgquist S, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Romieu I, Rinaldi S, Vineis P, Riboli E.

Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2562-9. doi: 10.1158/1055-9965.EPI-10-0447. Epub 2010 Aug 27.

9.

Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study.

Cantwell MM, Lacey JV Jr, Schairer C, Schatzkin A, Michaud DS.

Int J Cancer. 2006 Nov 15;119(10):2398-401.

10.

Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease.

Popat RA, Van Den Eeden SK, Tanner CM, McGuire V, Bernstein AL, Bloch DA, Leimpeter A, Nelson LM.

Neurology. 2005 Aug 9;65(3):383-90.

PMID:
16087902
11.

Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study.

Merritt MA, Riboli E, Murphy N, Kadi M, Tjønneland A, Olsen A, Overvad K, Dossus L, Dartois L, Clavel-Chapelon F, Fortner RT, Katzke VA, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Sieri S, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita HB, Peeters PH, Lund E, Nakamura A, Weiderpass E, Quirós JR, Agudo A, Molina-Montes E, Larrañaga N, Dorronsoro M, Cirera L, Barricarte A, Olsson Å, Butt S, Idahl A, Lundin E, Wareham NJ, Key TJ, Brennan P, Ferrari P, Wark PA, Norat T, Cross AJ, Gunter MJ.

BMC Med. 2015 Oct 30;13:252. doi: 10.1186/s12916-015-0484-3.

12.

Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.

Simon KC, Chen H, Gao X, Schwarzschild MA, Ascherio A.

Mov Disord. 2009 Jul 15;24(9):1359-65. doi: 10.1002/mds.22619.

13.

Reproductive and hormonal factors and mortality among women with colorectal cancer in the NIH-AARP Diet and Health Study.

Arem H, Park Y, Felix AS, Zervoudakis A, Brinton LA, Matthews CE, Gunter MJ.

Br J Cancer. 2015 Jul 28;113(3):562-8. doi: 10.1038/bjc.2015.224. Epub 2015 Jun 23.

14.

Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort.

Morton LM, Wang SS, Richesson DA, Schatzkin A, Hollenbeck AR, Lacey JV Jr.

Int J Cancer. 2009 Jun 1;124(11):2737-43. doi: 10.1002/ijc.24248.

15.

Reproductive life characteristics in females affected with Parkinson's disease and in healthy control subjects - a comparative study on Polish population.

Nitkowska M, Czyżyk M, Friedman A.

Neurol Neurochir Pol. 2014;48(5):322-7. doi: 10.1016/j.pjnns.2014.08.004. Epub 2014 Sep 16.

PMID:
25440010
16.

Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.

Weitmann K, Hirt C, Schwarz S, Rabkin C, Dölken G, Hoffmann W.

Cancer Causes Control. 2015 Mar;26(3):455-65. doi: 10.1007/s10552-015-0525-4. Epub 2015 Jan 30.

17.

Reproductive history, hormonal factors and the incidence of hip and knee replacement for osteoarthritis in middle-aged women.

Liu B, Balkwill A, Cooper C, Roddam A, Brown A, Beral V; Million Women Study Collaborators.

Ann Rheum Dis. 2009 Jul;68(7):1165-70. doi: 10.1136/ard.2008.095653. Epub 2008 Oct 28.

PMID:
18957480
18.

Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.

Tsilidis KK, Allen NE, Key TJ, Dossus L, Lukanova A, Bakken K, Lund E, Fournier A, Overvad K, Hansen L, Tjønneland A, Fedirko V, Rinaldi S, Romieu I, Clavel-Chapelon F, Engel P, Kaaks R, Schütze M, Steffen A, Bamia C, Trichopoulou A, Zylis D, Masala G, Pala V, Galasso R, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, van Duijnhoven FJ, Braem MG, Onland-Moret NC, Gram IT, Rodríguez L, Travier N, Sánchez MJ, Huerta JM, Ardanaz E, Larrañaga N, Jirström K, Manjer J, Idahl A, Ohlson N, Khaw KT, Wareham N, Mouw T, Norat T, Riboli E.

Br J Cancer. 2011 Oct 25;105(9):1436-42. doi: 10.1038/bjc.2011.371. Epub 2011 Sep 13.

19.

Hormone-related factors and post-menopausal onset depression: results from KNHANES (2010-2012).

Jung SJ, Shin A, Kang D.

J Affect Disord. 2015 Apr 1;175:176-83. doi: 10.1016/j.jad.2014.12.061. Epub 2015 Jan 14.

20.

Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.

Carrasquilla GD, Frumento P, Berglund A, Borgfeldt C, Bottai M, Chiavenna C, Eliasson M, Engström G, Hallmans G, Jansson JH, Magnusson PK, Nilsson PM, Pedersen NL, Wolk A, Leander K.

PLoS Med. 2017 Nov 17;14(11):e1002445. doi: 10.1371/journal.pmed.1002445. eCollection 2017 Nov.

Supplemental Content

Support Center